CoreWeave has shifted its business model to focus on long-term, take-or-pay contracts backed by a $129 billion contracted order book, providing high revenue visibility and durability. Currently, only 36% of its contracted GPU capacity is active, indicating significant future revenue potential as more capacity is energized. Despite risks related to leverage and execution, CoreWeave's premium position in AI infrastructure and margin expansion prospects support a positive re-rating and growth outlook.
Verisk Analytics introduced its new Verisk Fraud Discovery platform to enhance fraud prevention for insurers. Barclays adjusted the company's price target to $225, suggesting a 21.1% potential gain from the current stock price of $185.79. The company...
Adobe Inc. is undergoing a rare CEO transition with Anil Chakravarthy set to become CEO on December 1. Analyst opinions are divided: Oppenheimer rates Adobe as 'Perform' (hold), while Bank of America issues a 'Sell' rating with a $220 price target, c...
Canaan Inc. reported Q2 2026 results with an EPS loss of $0.01, better than the expected $0.10 loss, showing improved profitability. However, revenue was $4.63 million, below the $5.91 million forecast, indicating weaker sales in its crypto mining ha...
UBS analyst Gavin Parsons upgraded Lockheed Martin to a Buy rating with a $674 price target, implying a 28.3% potential gain. The aerospace and defense firm secured a $729 million contract with Sweden for its Himars rocket system, contributing to a r...
Investment firm BMO Capital downgraded Amgen's stock from "Outperform" to "Market Perform" following a major clinical trial failure by Novartis for a similar cholesterol drug. Novartis' drug pelacarsen failed in a late-stage Phase III trial, casting ...
